Pulse Biosciences (PLSE) Reports Q3 Loss of $0.21

Pulse Biosciences (NASDAQ: PLSE) reported Q3 EPS of ($0.21), versus ($0.10) reported last year.

Cash, cash equivalents, and investments totaled $18.7 million at September 30, 2016 compared to $20.7 million and $3.6 million at June 30, 2016 and December 31, 2015, respectively.

For earnings history and earnings-related data on Pulse Biosciences (PLSE) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Bristow Group to acquire Berry Aviation for $105 million
• Goldman "broadly" raises estimates for LTL and truckload stocks